JNJ vs PEBO · P/E 17, rev $49.37B vs P/E 11, rev $44.4M
Johnson & Johnson (JNJ) versus Peoples Bancorp Inc (PEBO) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Peoples Bancorp Inc (PEBO) is a banks - regional company listed on NASDAQ.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported PEBO revenue for 2026-06-30 was $44.4M. Net income was $57.0M. Revenue was up 98.6% from 2026-03-31 to 2026-06-30. PEBO currently screens at market cap $1.28B and trailing P/E 11.5.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. PEBO currently screens at market cap $1.28B and trailing P/E 11.5.
Not investment advice. Open the JNJ and PEBO stock pages for the full models.
Not investment advice.